병리학용 AI 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global AI in pathology market size is expected to reach USD 1232.30 Million in 2034 from USD 156.84 Million in 2025, growing at a CAGR of 25.74% during 2026-2034.This market is witnessing rapid growth driven by the increasing adoption of artificial intelligence in diagnostic processes. AI in pathology enables automated image analysis, improving accuracy and efficiency in disease detection. The growing prevalence of cancer and other chronic diseases is significantly contributing to market expansion, as healthcare providers seek advanced diagnostic tools to enhance patient outcomes.

Key drivers include advancements in machine learning algorithms, increasing digitalization of healthcare, and the need for faster and more accurate diagnostics. AI-powered pathology solutions can analyze large datasets, identify patterns, and assist pathologists in making informed decisions. The integration of AI with digital pathology platforms is also improving workflow efficiency. Additionally, the expansion of telepathology services is supporting market growth.

Future prospects for this market remain highly promising, with continuous innovation in AI technologies and data analytics. The development of more sophisticated algorithms and integration with other diagnostic tools will enhance capabilities. Emerging markets are expected to offer significant growth opportunities due to improving healthcare infrastructure. As the demand for precision medicine continues to rise, the AI in pathology market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Systems
• Software And Services

By Technology

• Machine Learning And Deep Learning
• Natural Language Processing
• Others

By Application

• Clinical Application
• Drug Discovery
• Others

By End-User

• Hospitals And Clinics
• Biotechnology And Pharma Companies
• Others

COMPANIES PROFILED

• Koninklijke Philips N.V., PathAI Inc., Aignostics GmbH, Hologic Inc., F. Hoffmann-La Roche Ltd, Aiforia Technologies Plc, Ibex Medical Analytics Inc., Paige Inc., Proscia Inc., Indica Labs Inc., FUJIFILM Healthcare Americas Corporation (formerly capturing Inspirata Inc.'s, asset portfolio)

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AI IN PATHOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software And Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AI IN PATHOLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Machine Learning And Deep Learning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Natural Language Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AI IN PATHOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Clinical Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AI IN PATHOLOGY MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals And Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Biotechnology And Pharma Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AI IN PATHOLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AI IN PATHOLOGY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Koninklijke Philips N.V
  • 10.2.2 PathAI Inc
  • 10.2.3 Aignostics GmbH
  • 10.2.4 Hologic Inc
  • 10.2.5 F. Hoffmann-La Roche Ltd
  • 10.2.6 Aiforia Technologies Plc
  • 10.2.7 Ibex Medical Analytics Inc
  • 10.2.8 Paige Inc
  • 10.2.9 Proscia Inc
  • 10.2.10 Indica Labs Inc
  • 10.2.11 FUJIFILM Healthcare Americas Corporation (formerly Capturing Inspirata Inc.'s Asset Portfolio)